Home Pilots RapidAI receives FDA 510(k) to identify potential pulmonary embolism Pilots RapidAI receives FDA 510(k) to identify potential pulmonary embolism By - May 24, 2022 50 0 Facebook Twitter Pinterest WhatsApp The Rapid PE Triage & Notification tool analyzes CT pulmonary angiograms to find potential cases and alert care teams. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Sydney-based medtech Echo IQ brings AI heart screening platform to the US Pilots - December 8, 2022 0 Mobile app gamifies communication training for dementia caregivers Pilots - July 19, 2024 0 Cerebral CMO defends company’s prescribing practices Pilots - May 2, 2022 0 Home care company Inbound Health raises $30M and more digital health fundings Pilots - September 20, 2023 0 Study: Internet searches for abortion medications surged after Roe draft leak Pilots - June 29, 2022 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3